HKU Scholars Hub: Browsing DSpace

Browsing by Author Nixon, AB

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 20 of 21 next >

Title	Author(s)	Issue Date	Views
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas Journal:Oncologist	Uronis, HE Bendell, JC Altomare, I Blobe, GC David Hsu, S Morse, MA Pang, H Yousuf Zafar, S Conkling, P Favaro, J Arrowood, CC Cushman, SM Meadows, KL Brady, JC Nixon, AB Hurwitz, HI	2013	75
A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer Journal:Anticancer Research	Wong, NS Fernando, NH Nixon, AB Cushman, S Aklilu, M Bendell, JC Morse, MA Blobe, GC Ashton, J Pang, H Hurwitz, HI	2011	50
Biomarker modulation in patients (pts) receiving TRC105 (T) and bevacizumab (B) in a phase Ib clinical trial Proceeding/Conference:Journal of Clinical Oncology	Liu, Y Clarke, J Starr, MD Brady, JC Pang, HMH Rushing, C Alvarez, D Adams, BJ Theuer, CP Hurwitz, H Nixon, AB	2014
Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance) Journal:Cancer Medicine	Hatch, AJ Sibley, AB Starr, MD Brady, JC Jiang, C Jia, J Bowers, DL Pang, H Owzar, K Niedzwiecki, D Innocenti, F Venook, AP Hurwitz, HI Nixon, AB The Alliance for Clinical Trials in Oncology	2016	30
Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer (APC): Results from CALGB 80303 (Alliance) Proceeding/Conference:Journal of Clinical Oncology	Clarke, JM Pang, HMH Starr, MD Hatch, AJ Kindler, HL O'Reilly, EM Innocenti, F Venook, AP Hurwitz, H Nixon, AB	2015
Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab Journal:Cancer Medicine	Liu, Y Starr, MD Bulusu, A Pang, HMH Wong, NS Honeycutt, W Amara, A Hurwitz, HI Nixon, AB	2013	61
Correlation of Src activation with response to dasatinib, capecitabine, oxaliplatin, and bevacizumab in advanced solid tumors Proceeding/Conference:Journal of Clinical Oncology	Strickler, JH McCall, S Nixon, AB Pang, HMH Rushing, C Arrowood, C Haley, S Meadows, K Hurwitz, H	2013	47
Direct Evidence of Targeted Inhibition by Anti-angiogenic Agents from a Wound-healing Model in Patients with Advance Solid Tumors Proceeding/Conference:Targeting VEGF-mediated Tumor Angiogenesis in Cancer Therapy Conference	Jia, J Dellinger, A Weiss, ES Bulusu, A Li, H Howard, L Kaplan, N Pang, HMH Hurwitz, H Nixon, AB	2014	43
Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data Journal:Cancer Informatics	Dellinger, AE Nixon, AB Pang, HMH	2014	37
Modulation of angiogenic biomarkers in patients receiving high-dose TRC105 Proceeding/Conference:Journal of Clinical Oncology	Liu, Y Starr, M Brady, JC Pang, HMH Dellinger, A Leigh, BR Theuer, CP Hurwitz, H Nixon, AB	2012	49
Modulation of angiogenic biomarkers in patients treated on a phase I study of TRC105 (anti-CD105 antibody) monotherapy for advanced solid tumors Proceeding/Conference:Journal of Clinical Oncology	Liu, Y Starr, M Pang, HMH Marcello, J Leigh, BR Theuer, CP Hurwitz, H Nixon, AB	2011	67
Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer Journal:Cancer Medicine	Liu, Y Starr, MD Brady, JC Dellinger, A Pang, HMH Adams, B Theuer, CP Lee, NY Hurwitz, HI Nixon, AB	7-Mar-2014	68
Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105 Journal:Molecular Cancer Therapeutics	Liu, Y Starr, MD Brady, JC Rushing, C Pang, H Adams, B Alvarez, D Theuer, CP Hurwitz, HI Nixon, AB	2018	15
Modulation of pharmacodynamic (PD) biomarkers in dermal biopsies from patients treated on a phase I study of bevacizumab (Bev) in combination with everolimus (Ev) and erlotinib (Erl) for advanced solid tumors Proceeding/Conference:Journal of Clinical Oncology	Jia, J Li, H Dellinger, A Pang, HMH Russell, KB Hurwitz, H Nixon, AB	2012	49
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors Journal:Cancer Medicine	Uronis, HE Cushman, SM Bendell, JC Blobe, GC Morse, MA Nixon, AB Dellinger, A Starr, MD Li, H Meadows, K Gockerman, J Pang, HMH Hurwitz, HI	2013	84
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors Journal:Invest New Drugs	Rangwala, F Bendell, JC Kozloff, MF Arrowood, CC Dellinger, A Meadows, J Tourt-Uhlig, S Murphy, J Meadows, KL Starr, A Broderick, S Brady, JC Cushman, SM Morse, MA Uronis, HE Hsu, SD Zafar, SY Wallace, J Starodub, AN Strickler, JH Pang, HMH Nixon, AB Hurwitz, HI	2014	59
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer Journal:Investigational New Drugs	Strickler, JH McCall, S Nixon, AB Brady, JC Pang, H Rushing, C Cohn, A Starodub, A Arrowood, C Haley, S Meadows, KL Morse, MA Uronis, HE Blobe, GC Hsu, SD Zafar, SY Hurwitz, HI	2014	61
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors Journal:Cancer Chemotherapy and Pharmacology	Uronis, HE Jia, J Bendell, J Howard, L Ready, NA Lee, PA Starr, MD Dellinger, A Pang, HMH Nixon, AB	2015
Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: Results from CALGB 80303 Proceeding/Conference:Journal of Clinical Oncology	Nixon, AB Pang, HMH Starr, M Hollis, D Friedman, PN Bertagnolli, MM Kindler, HL Goldberg, RM Venook, AP Hurwitz, H	2011	51
Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance) Journal:Clinical Cancer Research	Nixon, AB Nixon, AB Nixon, AB Pang, HMH Starr, MD Friedman, PN Bertagnolli, MM Kindler, HL Goldberg, RM Venook, AP Hurwitz, HI	2013

Showing results 1 to 20 of 21 next >